15-Deoxy-Δ
Antineoplastic Agents
/ pharmacology
Carcinoma, Renal Cell
/ drug therapy
Cell Line, Tumor
Cell Movement
/ drug effects
Down-Regulation
/ drug effects
Focal Adhesion Protein-Tyrosine Kinases
/ metabolism
Humans
Kidney Neoplasms
/ drug therapy
PPAR gamma
/ metabolism
Prostaglandin D2
/ analogs & derivatives
15-deoxy-△12,14-prostaglandin J2
cell migration
focal adhesion kinase
metastasis
renal cell carcinoma
Journal
Biological & pharmaceutical bulletin
ISSN: 1347-5215
Titre abrégé: Biol Pharm Bull
Pays: Japan
ID NLM: 9311984
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
7
1
2020
pubmed:
7
1
2020
medline:
11
11
2020
Statut:
ppublish
Résumé
Renal cell carcinoma (RCC) is one of the chemoresistant cancers. There is a pressing need to establish therapeutic approaches to prevent RCC proliferation and metastasis. The electrophilic 15-deoxy-Δ
Identifiants
pubmed: 31902920
doi: 10.1248/bpb.b19-00748
doi:
Substances chimiques
15-deoxyprostaglandin J2
0
Antineoplastic Agents
0
PPAR gamma
0
Focal Adhesion Protein-Tyrosine Kinases
EC 2.7.10.2
Prostaglandin D2
RXY07S6CZ2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM